These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38201813)

  • 21. Enhanced Antifungal Activity by Ab-Modified Amphotericin B-Loaded Nanoparticles Using a pH-Responsive Block Copolymer.
    Tang X; Dai J; Xie J; Zhu Y; Zhu M; Wang Z; Xie C; Yao A; Liu T; Wang X; Chen L; Jiang Q; Wang S; Liang Y; Xu C
    Nanoscale Res Lett; 2015 Dec; 10(1):969. PubMed ID: 26061446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A New Amphotericin B-loaded Trimethyl Chitosan Nanoparticles as a Drug Delivery System and Antifungal Activity on
    Nemati Shizari L; Mohammadpour Dounighi N; Bayat M; Mosavari N
    Arch Razi Inst; 2021; 76(3):571-586. PubMed ID: 34824750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Amphotericin B Hydrogel Composed of Poly(Vinyl Alcohol)/Borate Complex for Ophthalmic Formulation.
    Banshoya K; Shirakawa M; Hieda Y; Ohnishi M; Sato Y; Inoue A; Tanaka T; Kaneo Y
    Chem Pharm Bull (Tokyo); 2023; 71(1):70-73. PubMed ID: 36596514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucoadhesive phenylboronic acid conjugated chitosan oligosaccharide-vitamin E copolymer for topical ocular delivery of voriconazole: Synthesis, in vitro/vivo evaluation, and mechanism.
    Sun X; Sheng Y; Li K; Sai S; Feng J; Li Y; Zhang J; Han J; Tian B
    Acta Biomater; 2022 Jan; 138():193-207. PubMed ID: 34757228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
    Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
    Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.
    Zia Q; Khan AA; Swaleha Z; Owais M
    Int J Nanomedicine; 2015; 10():1769-90. PubMed ID: 25784804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphotericin B-silver hybrid nanoparticles: synthesis, properties and antifungal activity.
    Tutaj K; Szlazak R; Szalapata K; Starzyk J; Luchowski R; Grudzinski W; Osinska-Jaroszuk M; Jarosz-Wilkolazka A; Szuster-Ciesielska A; Gruszecki WI
    Nanomedicine; 2016 May; 12(4):1095-1103. PubMed ID: 26772425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal activity of oral (Tragacanth/acrylic acid) Amphotericin B carrier for systemic candidiasis: in vitro and in vivo study.
    Mohamed HA; Radwan RR; Raafat AI; Ali AE
    Drug Deliv Transl Res; 2018 Feb; 8(1):191-203. PubMed ID: 29280061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amphotericin B-Loaded Plant-Inspired Polyphenol Nanoparticles Enhance Its Antifungal Activity and Biocompatibility.
    Sunoqrot S; Al-Bakri AG; Ibrahim LH; Aldaken N
    ACS Appl Bio Mater; 2022 Nov; 5(11):5156-5164. PubMed ID: 36241585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
    Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
    Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphotericin B aggregation inhibition with novel nanoparticles prepared with poly(epsilon-caprolactone)/poly(n,n-dimethylamino-2-ethyl methacrylate) diblock copolymer.
    Shim YH; Kim YC; Lee HJ; Bougard F; Dubois P; Choi KC; Chung CW; Kang DH; Jeong YI
    J Microbiol Biotechnol; 2011 Jan; 21(1):28-36. PubMed ID: 21301189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphotericin B-PEG Conjugates of ZnO Nanoparticles: Enhancement Antifungal Activity with Minimal Toxicity.
    Alshahrani SM; Khafagy ES; Riadi Y; Al Saqr A; Alfadhel MM; Hegazy WAH
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanocarriers Provide Sustained Antifungal Activity for Amphotericin B and Miltefosine in the Topical Treatment of Murine Vaginal Candidiasis.
    de Bastiani FWMDS; Spadari CC; de Matos JKR; Salata GC; Lopes LB; Ishida K
    Front Microbiol; 2019; 10():2976. PubMed ID: 31998264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low intensity ultrasound-mediated drug-loaded nanoparticles intravaginal drug delivery: an effective synergistic therapy scheme for treatment of vulvovaginal candidiasis.
    Yang M; Cao Y; Zhang Z; Guo J; Hu C; Wang Z; Du Y
    J Nanobiotechnology; 2023 Feb; 21(1):53. PubMed ID: 36782198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
    Alvarez C; Shin DH; Kwon GS
    Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
    Ludwig DB; de Camargo LEA; Khalil NM; Auler ME; Mainardes RM
    Mycopathologia; 2018 Aug; 183(4):659-668. PubMed ID: 29497926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-assembling cashew gum-graft-polylactide copolymer nanoparticles as a potential amphotericin B delivery matrix.
    Richter AR; Carneiro MJ; de Sousa NA; Pinto VPT; Freire RS; de Sousa JS; Mendes JFS; Fontenelle ROS; Feitosa JPA; Paula HCB; Goycoolea FM; de Paula RCM
    Int J Biol Macromol; 2020 Jun; 152():492-502. PubMed ID: 32097738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
    Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.
    Fukui H; Koike T; Nakagawa T; Saheki A; Sonoke S; Tomii Y; Seki J
    Int J Pharm; 2003 Nov; 267(1-2):101-12. PubMed ID: 14602388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.